An Exploratory Study Conducted as an add-on to Clinical Trial 11286, to Evaluate the Metabolic Effect of up to 12 Weeks Treatment With Sertindole and Olanzapine in Patients With Schizophrenia. [FOLLOW-UP to 700042728]

Trial Profile

An Exploratory Study Conducted as an add-on to Clinical Trial 11286, to Evaluate the Metabolic Effect of up to 12 Weeks Treatment With Sertindole and Olanzapine in Patients With Schizophrenia. [FOLLOW-UP to 700042728]

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Sep 2013

At a glance

  • Drugs Sertindole (Primary) ; Olanzapine
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Lundbeck A/S
  • Most Recent Events

    • 11 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top